ArticleBlood2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Christopher P Mill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this papercites it
ArticleBlood2019
Christopher P Mill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.